Author
Listed:
- Nicole Vincent Jordan
(Massachusetts General Hospital Cancer Center, Harvard Medical School)
- Aditya Bardia
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Ben S. Wittner
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Cyril Benes
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Matteo Ligorio
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Yu Zheng
(Massachusetts General Hospital Cancer Center, Harvard Medical School)
- Min Yu
(Massachusetts General Hospital Cancer Center, Harvard Medical School
† Present address: Department of Stem Cell Biology and Regenerative Medicine, University of Southern California, California 90033, USA.)
- Tilak K. Sundaresan
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Joseph A. Licausi
(Massachusetts General Hospital Cancer Center, Harvard Medical School)
- Rushil Desai
(Massachusetts General Hospital Cancer Center, Harvard Medical School)
- Ryan M. O’Keefe
(Massachusetts General Hospital Cancer Center, Harvard Medical School)
- Richard Y. Ebright
(Massachusetts General Hospital Cancer Center, Harvard Medical School)
- Myriam Boukhali
(Massachusetts General Hospital Cancer Center, Harvard Medical School)
- Srinjoy Sil
(Massachusetts General Hospital Cancer Center, Harvard Medical School)
- Maristela L. Onozato
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Anthony J. Iafrate
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Ravi Kapur
(Center for Bioengineering in Medicine and Shriners Hospital, Harvard Medical School)
- Dennis Sgroi
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- David T. Ting
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Mehmet Toner
(Harvard Medical School
Center for Bioengineering in Medicine and Shriners Hospital, Harvard Medical School)
- Sridhar Ramaswamy
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Wilhelm Haas
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Shyamala Maheswaran
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School)
- Daniel A. Haber
(Massachusetts General Hospital Cancer Center, Harvard Medical School
Harvard Medical School
Howard Hughes Medical Institute)
Abstract
Patient-derived circulating tumour cells are used to characterize the dynamics and underlying plasticity of HER2 expression in non-HER2-amplified breast tumours.
Suggested Citation
Nicole Vincent Jordan & Aditya Bardia & Ben S. Wittner & Cyril Benes & Matteo Ligorio & Yu Zheng & Min Yu & Tilak K. Sundaresan & Joseph A. Licausi & Rushil Desai & Ryan M. O’Keefe & Richard Y. Ebrigh, 2016.
"HER2 expression identifies dynamic functional states within circulating breast cancer cells,"
Nature, Nature, vol. 537(7618), pages 102-106, September.
Handle:
RePEc:nat:nature:v:537:y:2016:i:7618:d:10.1038_nature19328
DOI: 10.1038/nature19328
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Xiaoxu Guo & Fanghe Lin & Chuanyou Yi & Juan Song & Di Sun & Li Lin & Zhixing Zhong & Zhaorun Wu & Xiaoyu Wang & Yingkun Zhang & Jin Li & Huimin Zhang & Feng Liu & Chaoyong Yang & Jia Song, 2022.
"Deep transfer learning enables lesion tracing of circulating tumor cells,"
Nature Communications, Nature, vol. 13(1), pages 1-14, December.
- G. Gambardella & G. Viscido & B. Tumaini & A. Isacchi & R. Bosotti & D. di Bernardo, 2022.
"A single-cell analysis of breast cancer cell lines to study tumour heterogeneity and drug response,"
Nature Communications, Nature, vol. 13(1), pages 1-12, December.
- Yuelong Yan & Hongqi Teng & Qinglei Hang & Lavanya Kondiparthi & Guang Lei & Amber Horbath & Xiaoguang Liu & Chao Mao & Shiqi Wu & Li Zhuang & M. James You & Masha V. Poyurovsky & Li Ma & Kellen Olsze, 2023.
"SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells,"
Nature Communications, Nature, vol. 14(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:537:y:2016:i:7618:d:10.1038_nature19328. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.